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apparent diffusion coefficient maps. CTH were found signif-
icantly associated with age and independently related to the 
volume of white matter hyperintensities but not to that of 
lacunar infarctions or to cerebral atrophy after adjustment 
for age and sex. No significant association was found be-
tween CTH and global cognitive performances.  Conclusion: 
CTH are observed on FLAIR images in a sizeable proportion 
of CADASIL patients. They are mainly related to the extent of 
white matter hyperintensities and do not correlate with cog-
nitive decline. Demyelination and/or loss of glial cells appear 
to be the most plausible cause of these confluent signal 
changes in the thalamus.  Copyright © 2010 S. Karger AG, Basel 
 Introduction 
 The current imaging concepts of small-vessel disease 
are based on the presence of confluent ischemic lesions in 
the white matter (‘leukoaraiosis’) associated with lacunar 
infarcts. The presence of confluent MRI lesions within the 
deep grey matter, particularly within the thalamus, is not 
a rare feature in patients with small-vessel disease (own 
observations). However, these lesions have received little 
attention in the literature, and there is no detailed descrip-
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 Abstract 
 Background: CADASIL is responsible for diffuse hyperinten-
sities in the white matter on FLAIR images. These lesions are 
often associated with focal lesions in the basal ganglia such 
as lacunar infarctions. The prevalence and significance of
diffuse or confluent thalamic hyperintensities (CTH) remain 
unknown.  Methods: The frequency of hyperintensities on 
FLAIR images in the thalamus was assessed in 147 CADASIL 
patients, and signal abnormalities on both FLAIR and T 1 -
weighted images were categorized as focal/punctuate or 
diffuse/confluent by the same reader. The areas of increased 
diffusion were also analyzed on apparent diffusion coeffi-
cient maps. The association of CTH with vascular risk factors, 
the main clinical manifestations of the disease and MRI mark-
ers (brain parenchymal fraction, volume of white matter hy-
perintensities, volume of lacunar infarcts and number of mi-
crobleeds) was analyzed with generalized linear regression 
models.  Results: CTH were detected in 12% of the CADASIL 
subjects in association with hypointensities on T 1 -weighted 
images. CTH corresponded to areas of increased diffusion on 
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tion regarding their neuroimaging features, their correla-
tion with other imaging findings and their potential clin-
ical correlates. We set out to provide these informations 
in Cerebral Autosomal Dominant Arteriopathy with Sub-
cortical Infarcts and Leukoencephalopathy (CADASIL), a 
model of ischemic small vessel disease caused by muta-
tions of the  NOTCH3 gene on chromosome 19  [1–5] .
 In symptomatic and asymptomatic CADASIL pa-
tients, cerebral MRI can show diffuse white matter hy-
perintensities (WMH) on FLAIR or T 2 -weighted images 
 [6] . WMH presumably appear during the third decade 
and are constant after 40 years  [7–9] . They are of variable 
extent, have a symmetrical distribution and initially pre-
dominate in the deepest territories of cerebral penetrat-
ing arteries. They progressively become confluent and 
diffuse. WMH are associated with lacunar infarcts which 
are usually well delineated on FLAIR or 3-dimensional 
T 1 -weighted images. T 2 or FLAIR hyperintensities are 
also observed in basal ganglia and within the brainstem 
 [10] . Microbleeds and dilated perivascular spaces are also 
frequently detected  [11–14] .
 In the deep grey nuclei of CADASIL patients, most 
signal abnormalities have been reported as focal or punc-
tiform lesions that usually correspond either to dilated 
perivascular spaces or to lacunar infarctions. They are 
hyperintense on T 2 -weighted images and hypointense on 
T 1 -weighted images. Only in anecdotal reports have dif-
fuse signal abnormalities distinct from these focal lesions 
been described in the central grey matter on T 2 -weighted 
or FLAIR images, mostly within the thalamus  [8, 15] . The 
frequency of thalamic confluent lesions and their rela-
tionship with the other MRI markers of the disease are 
unknown. In addition, their clinical significance and po-
tential impact on cognition has not been evaluated  [16] .
 In this study, we determined the frequency of signal 
abnormalities in thalamic nuclei as seen on T 1 and FLAIR 
images and on apparent diffusion coefficient (ADC) 
maps in a large population of CADASIL patients. We de-
scribed the main characteristics of diffuse or confluent 
thalamic hyperintensities (CTH) as observed on FLAIR 
images in patients with CADASIL.
 Material and Methods 
 Subjects 
 Data were obtained from an ongoing multicenter prospective 
cohort study of subjects with CADASIL. A total of 147 patients 
were enrolled into the study at the Lariboisière hospital (Paris) and 
at the Ludwig Maximilian University (Munich) between 2003 and 
2005. The complete study design has been detailed elsewhere  [17] .
 Magnetic Resonance Imaging 
 MRI scans were performed by the use of a 1.5-tesla system [Vi-
sion, Siemens (Munich) or Signa General Electric Medical Systems 
(Paris)]. T 1 -weighted axial sequences, FLAIR, T 2 *  -weighted GE 
planar imaging and diffusion-weighted imaging were performed. 
The protocol parameters have been previously detailed  [17] .
 Image Processing and Analysis 
 The total volume of WMH, lacunes and brain parenchymal 
fraction defined as the ratio of brain tissue volume to total intra-
cranial cavity volume was assessed as previously described  [17, 
18] .
 A qualitative visual scale was used by a neurologist blinded to 
clinical data (M.J.). The following characteristics were rated for 
each scan in the thalamus: (1) presence or absence of hyperinten-
sities on FLAIR images, (2) presence or absence of hypointensities 
on T 1 -weighted images, (3) focal or punctuate versus diffuse or 
confluent hyperintensities (CTH), (4) visible increase in diffusion 
on ADC maps in areas corresponding to CTH, and (5) presence 
or absence of microbleeds on T 2 *  -weighted images. The presence 
or absence of hyperintensities was also systematically assessed on 
FLAIR images in the internal capsule, the caudate nuclei and the 
putamen.
 Statistical Methods 
 In this study, 145 cerebral MRIs were analyzed. In addition, 20 
randomized MRIs were used to estimate the intra- and interob-
server reliability of the visual scale.   statistics were used and in-
terpreted according to the Landis and Koch scale  [19] . The reli-
ability for detection of thalamic signal abnormalities on FLAIR 
images (as assessed by M.J. and D.H.) was excellent (intrarater 
agreement,   = 0.78; interrater agreement,   = 0.76). The intra-
rater agreement for categorization of thalamic lesions as focal/
punctuate or confluent/diffuse was also excellent (  = 0.89), and 
the interrater agreement for categorization was substantial (  = 
0.65).
 The clinical and demographic characteristics and distribution 
of cerebral MRI parameters were described using   2 test for cat-
egorial variables and Student’s t test or analysis of variance for 
continuous variables. Regression models were used to evaluate 
the factors associated with CTH. Covariates with a p value  1 0.2 
in univariate analysis were introduced in the multivariate models 
in addition to potential confounding factors. Generalized linear 
regression models were used to study the relationships between 
CTH and cerebral lesion volumes. All models were adjusted for 
age and sex. Significance was considered when the p values were 
 ! 0.05. All statistical tests were performed with SAS 9.1.
 Results 
 Main Characteristics of the Population 
 The men were older than the women at the time of 
MRI examination (52 vs. 48 years, p = 0.03). In univariate 
analysis, the vascular risk factors and main clinical char-
acteristics of the disease did not differ between these two 
groups. All subjects (mean age  8 SD = 52  8 11 years) 
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presented with MRI signal abnormalities ( table  1 ), in-
cluding WMH in all subjects, lacunar infarctions in 92% 
(n = 129) and microbleeds in 35% (n = 51).
 Frequency of Confluent/Diffuse Thalamic Signal 
Abnormalities 
 CTH were observed in 12% of the patients (n = 17)
on FLAIR images as shown in  table 2 . All patients with 
CTH had superimposed thalamic hypointensities on T 1 -
weighted images.
 The visual examination revealed that, in the presence 
of CTH, an increase in diffusion was detected on ADC 
maps in 82% of the cases (n = 14). A strip-like aspect was 
detected in 3 cases, always in the presence of ipsilateral 
hyperintense lesions located in the internal capsule.  Fig-
ure 1 shows different patterns of CTH in 6 patients.
 In the whole cohort, punctuate or focal hyperintensi-
ties in the thalamus were detected on FLAIR images in 
34% of the subjects (n = 49). On T 2 *  -weighted images, 
microbleeds were found in the thalamus in 12% of the 
patients (n = 18).
 Relationships between CTH and the Main Clinical or 
MRI Parameters 
 Univariate analysis showed that CTH were associated 
with age (p = 0.002) but not with the presence of vascular 
risk factors, nor with any of the main clinical manifesta-
tions of the disease ( table 2 ). In addition, no significant 
association was found between CTH and the Mattis De-
mentia Rating scale after adjustment for age and sex 
(130.4  8 2.8 vs. 139  8 4.8, p = 0.12). While CTH were 
found to be significantly associated with the volume of 
WMH and with the brain volume in univariate analysis, 
multivariate models showed that, among the different 
MRI markers, CTH were only related to WMH (p = 0.03) 
after adjustment for age and sex ( table 3 ). Univariate anal-
ysis showed that CTH were also associated with the pres-
ence of hyperintensities in the internal capsule (OR = 5.2; 
95% CI = 1.2–22.3), in the caudate nuclei (OR = 7.9; 95% 
CI = 1.3–47) and within the putamen (OR = 11.4; 95%
CI = 3.0–43.4).
Table 1. M ain clinical characteristics of the population
Characteristics
Mean age, years 52811
Hypertension 26 (18)
Hypercholesterolemia 62 (43)
Diabetes 3 (2)
Past or current smoker 72 (50)
Body mass index >25 66 (45)
Mood disorders 69 (47)
Migraine with aura 70 (48)
History of stroke or TIA 99 (69)
Dementia 22 (15)
Total = 145. Figures are means 8 SD or numbers of cases with 
percentages in parentheses. TIA = Transient ischemic attack.
Table 2.  Main clinical characteristics of the disease in the pres-
ence or absence of CTH
Main clinical characteristics CTH – CTH + p
Number 128 (88) 17 (12)
Male sex 56 (44) 7 (41) 0.84
Age, years 50.9810.9 59.487.8 0.002
Hypertension 24 (19) 2 (12) 0.47
Hypercholesterolemia 55 (43) 7 (41) 0.87
Diabetes 3 (2.4) 0 (0) 0.52
Past or current smoker 67 (52) 5 (29) 0.08
Body mass index >25 59 (46) 7 (41) 0.70
Mood disorders 62 (49) 7 (41) 0.44
Migraine with aura 63 (49) 7 (41) 0.53
History of TIA or stroke 87 (69) 12 (71) 0.89
Dementia 19 (15) 3 (18) 0.79
Figures are means 8 SD or numbers of cases with percent-
ages in parentheses. TIA = Transient ischemic attack.
Table 3.  Association between CTH and the other MRI markers of 
the disease
CTH– CTH+ p
Univariate analysis
WMH volume 7.32 (0.40) 9.76 (1.10) 0.04
Lacunar volume 0.09 (0.01) 0.08 (0.04) 0.81
BPF 80.1 (0.49) 83.5 (1.35) 0.02
Multivariate analysis
WMH volume 6.92 (0.41) 9.56 (1.12) 0.03
Lacunar volume 0.07 (0.01) 0.07 (0.02) 0.91
BPF 80.4 (0.48) 82.8 (1.34) 0.09
Univariate and multivariate analyses after adjustment for age 
and sex. Figures are means with standard errors in parentheses. 
BPF = Brain parenchymal fraction.
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 Discussion 
 Among 145 patients with CADASIL, we observed that 
12% presented with confluent or diffuse hyperintensities 
in the thalamus on FLAIR images. These signal abnor-
malities were found to be associated with age and with 
the volume of WMH but not with the load of lacunar in-
farctions, number of microbleeds or with cerebral atro-
phy. These findings suggest that CTH are more related to 
the extent of leukoaraiosis than to the accumulation of 
focal ischemic lesions or to global cerebral tissue loss in 
CADASIL patients. The lack of a relationship between 
CTH and clinical severity is also in line with recent data 
indicating that the extent of WMH, in contrast to the load 
of lacunar infarctions and degree of cerebral atrophy, 
does not have a significant and independent impact on 
the severity of cognitive decline in this disorder  [20, 21] .
 The pathological lesions underlying CTH are still un-
known. A plausible hypothesis is that CTH are mainly 
related to diffuse demyelination within the thalamus. 
Diffuse thalamic T 2 hyperintensities as observed in the 
present study have been previously reported in pure dys-
myelinating disorders such as in maple syrup urine dis-
ease  [22] . Demyelination is also a common feature in leu-
koaraiosis  [23] and has been reported in the white matter 
as well as in subcortical grey matter in CADASIL patients 
 [24, 25] . Molko et al.  [26, 27] previously observed an ear-
ly increase in diffusion and decrease in anisotropy in the 
thalamus of 20 CADASIL patients that is also compatible 
with a loss of orientated myelin fibers. In the present 
study, we observed a similar increase in thalamic diffu-
sion overlapping the diffuse or confluent MRI thalamic 
signal changes.
 Other mechanisms may also play a role. Diffuse reduc-
tion in glial cells in the thalamus as already reported in 
animal models of chronic ischemia may contribute to 
CTH  [28] . Wallerian degeneration after focal ischemic le-
sions in thalamofugal or thalamopetal fibers may be im-
plicated  [26, 29] . The observation of a strip-like aspect in 
 Fig. 1. Axial MRI slices showing various patterns of diffuse or 
confluent signal abnormalities in the thalamus in CADASIL pa-
tients. From left to right: FLAIR images, T 1 -weighted images and 
ADC maps are shown. Different patterns of MR signal abnor-
malities are detected in the thalamus: more or less diffuse hyper-
intensities are visible on FLAIR images corresponding to a super-
imposed area of increased diffusion on ADC maps, in the absence 
of focal hypointensities suggestive of lacunar infarctions on T 1 -
weighted images (subjects  a – d ); confluent but more limited hy-
perintensities with a strip-like aspect on FLAIR images are de-
tected in patient e and in patient f. Note that strip-like lesions were 
observed in the thalamus in patients e and f in the presence of 
ipsilateral hyperintense lesions within the internal capsule (sug-
gestive of wallerian degeneration of intrathalamic myelin fibers – 
red arrows). 
a
 b 
 c 
 d 
 e 
 f 
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some cases of CTH in relation to an ipsilateral lesion in 
the internal capsule are in support of this latter hypoth-
esis. Other underlying processes cannot be excluded. 
Particularly, an increased number of dilated perivascular 
spaces, a frequent pathological feature of CADASIL, is 
also a potential source of confluent T 2 hyperintensities 
 [30] . However, both the location and distribution of sig-
nal changes with the diffuse pattern and/or a strip-like 
aspect seem unlikely to be related to such a process.
 This study has several limitations. We analyzed only 
diffuse or confluent signal changes in the thalamus and 
not in the other grey nuclei. This choice was made be-
cause the reliability of visual analysis of signal changes 
within the putamen or in the caudate nuclei on FLAIR 
images was much less satisfactory than within the thala-
mus (data not shown). The frequent association of dilated 
perivascular spaces and lacunar infarctions in the puta-
men or caudate nuclei is mainly responsible for this dis-
crepancy. Because we performed the study based on 
FLAIR images with a specific sequence, we cannot ex-
clude a different frequency of CTH using other MRI pa-
rameters (such as T 2 -weighted or proton density images). 
Finally, the analysis was based on visual examination but 
not on quantitative data in the thalamus.
 In conclusion, diffuse and confluent hyperintensities 
are observed on FLAIR images in the thalamus in  1 10% 
of the CADASIL patients. These MRI signal changes are 
associated with water diffusion increase that presumably 
reflects significant underlying microstructural changes. 
The association with WMH but not with the other MRI 
markers as well as the topographic distribution of signal 
changes suggests that demyelination is most likely related 
to CTH. Whether chronic ischemia is responsible for dif-
fuse demyelination or glial cell loss underlying CTH will 
require further investigation.
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